Ligand validation:3NWX

KVS: N~2~-[(2R,5S)-5-({(2S,3S)-2-[(N-acetyl-L-threonyl)amino]-3-methylpent-4-enoyl}amino)-2-butyl-4,4-dihydroxynonanoyl]-L-glutaminyl-L-argininamide

KVS is a Ligand Of Interest in 3NWX designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3NWX_KVS_B_100	35%	26%	0.162	0.851	1.56	1.57	2	4	0	0	100%	1
3DCR_KVS_B_101	70%	24%	0.1	0.918	1.81	1.46	6	9	1	0	100%	1
6KMP_KVS_B_201	83%	12%	0.097	0.956	2.07	2.21	11	17	7	0	100%	0.7
3NXN_KVS_A_204	41%	36%	0.183	0.898	1.63	0.98	2	4	3	0	100%	0.9643

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.